Abstract:Introduction: The U1 small nuclear RNA (snRNA) forms ribonucleoprotein particles (RNPs) such as U1 snRNP and U1-TAF15 snRNP. U1 snRNP is one of the most studied RNPs due to its critical role in pre-mRNA splicing in defining the 5 splice site (5ss) of every exon through direct interactions with sequences at exon/intron junctions. Recent reports support the role of U1 snRNP in all steps of transcription, namely initiation, elongation, and termination. Functions of U1-TAF15 snRNP are less understood, though it associates with the transcription machinery and may modulate pre-mRNA splicing by interacting with the 5ss and/or 5ss-like sequences within the pre-mRNA. An anti-U1 antisense oligonucleotide (ASO) that sequesters the 5 end of U1 snRNA inhibits the functions of U1 snRNP, including transcription and splicing. However, it is not known if the inhibition of U1 snRNP influences post-transcriptional regulation of pre-mRNA splicing through deep intronic sequences. Methods: We examined the effect of an anti-U1 ASO that sequesters the 5 end of U1 snRNA on transcription and splicing of all internal exons of the spinal muscular atrophy (SMA) genes, SMN1 and SMN2 . Our study was enabled by the employment of a multi-exon-skipping detection assay (MESDA) that discriminates against prematurely terminated transcripts. We employed an SMN2 super minigene to determine if anti-U1 ASO differently affects splicing in the context of truncated introns. Results: We observed substantial skipping of multiple internal exons of SMN1 and SMN2 triggered by anti-U1 treatment. Suggesting a role for U1 snRNP in interacting with deep intronic sequences, early exons of the SMN2 super minigene with truncated introns were resistant to anti-U1 induced skipping. Consistently, overexpression of engineered U1 snRNAs targeting the 5ss of early SMN1 and SMN2 exons did not prevent exon skipping caused by anti-U1 treatment. Discussion: Our results uncover a unique role of the U1 snRNA-associated RNPs in splicing regulation executed through deep intronic sequences. Findings are significant for developing novel therapies for SMA based on deep intronic targets.

Alu insertion-mediated dsRNA structure formation with pre-existing Alu elements as a disease-causing mechanism

insertion-mediated dsRNA structure formation with pre-existing elements as a novel disease-causing mechanism

Inverted Alu repeats: friends or foes in the human transcriptome

Alternative polyadenylation determines the functional landscape of inverted Alu repeats

Complementary Alu sequences mediate enhancer–promoter selectivity

Intronic Alus Influence Alternative Splicing

Structural determinants of inverted Alu-mediated backsplicing revealed by -MaP and -JuMP

Intron-targeted mutagenesis reveals roles for<i>Dscam1</i>RNA pairing-mediated splicing bias in neuronal wiring

The Ighmbp2 Helicase Structure Reveals the Molecular Basis for Disease-Causing Mutations in DMSA1

U1 snRNA interactions with deep intronic sequences regulate splicing of multiple exons of spinal muscular atrophy genes

Structural Variation of Alu Element and Human Disease

Evolution of a Splice Variant That Acts As an Endogenous Antagonist of the Original INSL3 in Primates.

A Splicing Silencer Insmn2intron 6 is Critical in Spinal Muscular Atrophy

Processing of Alu small RNAs by DICER/ADAR1 complexes and their RNAi targets

Insertion of an Alu Element in a Lncrna Leads to Primate-Specific Modulation of Alternative Splicing

A gene expression restriction network mediated by sense and antisense Alu sequences located on protein-coding messenger RNAs

Alu RNA Structural Features Modulate Immune Cell Activation and A-to-I Editing of Alu RNAs Is Diminished in Human Inflammatory Bowel Disease

A splicing silencer in SMN2 intron 6 is critical in spinal muscular atrophy

A Novel Nonsense INS Mutation Causes Inefficient Preproinsulin Translocation Into the Endoplasmic Reticulum

Mutation of two intronic nucleotides alters RNA structure and dynamics inhibiting MBNL1 and RBFOX1 regulated splicing of the Insulin Receptor

Temporal and tissue specific regulation of RP-associated splicing factor genes PRPF3, PRPF31 and PRPC8--implications in the pathogenesis of RP